Repeatability and effect of blinding of fructose breath tests in patients with functional gastrointestinal disorders-Reference-Cited by-同舟云学术

Repeatability and effect of blinding of fructose breath tests in patients with functional gastrointestinal disorders

Published:2018-11-04 Issue:2 Volume:31 Page:e13497
ISSN:1350-1925
Container-title:Neurogastroenterology & Motility
language:en
Short-container-title:Neurogastroenterology & Motility

Author:

Wilder‐Smith Clive H.¹^ORCID,Olesen Søren S.²,Materna Andrea¹,Drewes Asbjørn M.²

Affiliation:

1. Brain‐Gut Research Group Gastroenterology Group Practice Bern Switzerland

2. Mech‐Sense, Department of Gastroenterology and Hepatology Aalborg University Hospital Aalborg Denmark

Funder

Brain-Gut Research Group, Bern, Switzerland

Forschungsstftung Hirslanden, Zurich, Switzerland

Publisher

Wiley

Subject

Gastroenterology,Endocrine and Autonomic Systems,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/nmo.13497

Reference26 articles.

1. Hydrogen and Methane-Based Breath Testing in Gastrointestinal Disorders: The North American Consensus

2. The clinical value of breath hydrogen testing

3. Breath tests and irritable bowel syndrome

4. Methodology and indications of H2‐breath testing in gastrointestinal diseases: the Rome Consensus Conference;Gasbarrini A;Aliment Pharmacol Ther,2009

5. Methods and functions: Breath tests

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Adult Carbohydrate Perception Questionnaire Identifies Patients with Lactose or Fructose Intolerance Who Respond to Diet;Digestive Diseases;2024

2. CLINICAL EFFICACY AND SAFETY OF DIET CONTROL THERAPY COMBINED WITH DIGESTIVE ENZYME PREPARATION IN TREATING FUNCTIONAL GASTROINTESTINAL DISORDERS;ACTA MEDICA MEDITERR;2022

3. Update S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) – Juni 2021 – AWMF-Registriernummer: 021/016;Zeitschrift für Gastroenterologie;2021-12

4. Adverse events in trials of licensed drugs for irritable bowel syndrome with constipation or diarrhea: Systematic review and meta‐analysis;Neurogastroenterology & Motility;2021-10-20

5. Fructose intolerance is not associated with malabsorption in patients with functional gastrointestinal disorders;Neurogastroenterology & Motility;2021-04-12